These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34427018)

  • 21. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients.
    Lee KB; Kim YS; Lee JM
    J Gynecol Oncol; 2018 Jan; 29(1):e5. PubMed ID: 29185263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
    Park JY; Chong GO; Park JY; Chung D; Lee YH; Lee HJ; Hong DG; Han HS; Lee YS
    Gynecol Oncol; 2020 Oct; 159(1):157-163. PubMed ID: 32741542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
    Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
    Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
    Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
    Resende U; Cabello C; Ramalho SOB; Zeferino LC
    BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico.
    Isla-Ortiz D; Palomares-Castillo E; Mille-Loera JE; Ramírez-Calderón N; Mohar-Betancourt A; Meneses-García AA; Reynoso-Noverón N
    Oncologist; 2020 Sep; 25(9):e1363-e1371. PubMed ID: 32390238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: A retrospective study.
    Yan W; Qiu S; Ding Y; Zhang Q; Si L; Lv S; Liu L
    Medicine (Baltimore); 2019 Oct; 98(40):e17301. PubMed ID: 31577720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of adjuvant radiation therapy and prognostic factors in early stage uterine cervical cancer.
    Kim HJ; Rhee WJ; Choi SH; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
    Radiat Oncol J; 2015 Jun; 33(2):126-33. PubMed ID: 26157682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
    Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
    Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    J Obstet Gynaecol Res; 2017 Apr; 43(4):617-626. PubMed ID: 28190285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.
    Kim H; Park W; Kim YS; Kim YJ
    J Gynecol Oncol; 2020 May; 31(3):e35. PubMed ID: 31912685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm.
    Takada M; Sugimoto M; Masuda N; Iwata H; Kuroi K; Yamashiro H; Ohno S; Ishiguro H; Inamoto T; Toi M
    Breast Cancer Res Treat; 2018 Dec; 172(3):611-618. PubMed ID: 30194511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic model in patients with early-stage squamous cell carcinoma of the uterine cervix: a combination of invasive margin pathological characteristics and lymphovascular space invasion.
    Khunamornpong S; Lekawanvijit S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2013; 14(11):6935-40. PubMed ID: 24377504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer.
    Zhang C; Li Y; Ji R; Zhang W; Zhang C; Dan Y; Qian H; He A
    Onco Targets Ther; 2019; 12():9559-9568. PubMed ID: 32009792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.